Regeneron Pharmaceuticals
REGN
#293
Rank
HK$648.66 B
Marketcap
HK$6,136
Share price
1.57%
Change (1 day)
9.43%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): HK$40.80 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are HK$14.34 Billion. , an increase over its 2024 earnings that were of HK$37.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 HK$40.92 B9.43%
2024 HK$37.39 B13.83%
2023 HK$32.85 B-13.57%
2022 HK$38.01 B-47.9%
2021 HK$72.95 B144.75%
2020 HK$29.80 B56.86%
2019 HK$19.00 B-4.87%
2018 HK$19.97 B22.86%
2017 HK$16.26 B56.3%
2016 HK$10.40 B8.55%
2015 HK$9.58 B54.53%
2014 HK$6.20 B11.14%
2013 HK$5.58 B72.13%
2012 HK$3.24 B-285.93%
2011 -HK$1.75 Billion121.73%
2010 -HK$0.79 Billion37.18%
2009 -HK$0.58 Billion-14.6%
2008 -HK$0.68 Billion-25.02%
2007 -HK$0.9 Billion6.32%
2006 -HK$0.85 Billion-186.52%
2005 HK$0.97 B2103.7%
2004 HK$44.17 M-105.66%
2003 -HK$0.79 Billion-18.18%
2002 -HK$0.96 Billion42.33%
2001 -HK$0.68 Billion129.35%
2000 -HK$0.3 Billion51.87%
1999 -HK$0.2 Billion92.19%
1998 -HK$0.11 Billion66.23%
1997 -HK$60.24 Million-55.49%
1996 -HK$0.14 Billion103.53%
1995 -HK$66.5 Million-70.89%
1994 -HK$0.23 Billion-26.08%
1993 -HK$0.31 Billion114.67%
1992 -HK$0.15 Billion196.77%
1991 -HK$48.51 Million87.88%
1990 -HK$25.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$253.44 B 519.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.92 B 212.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
HK$64.49 B 57.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$71.19 B 73.98%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$14.89 B-63.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$1.01 B-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA